These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8676890)

  • 1. Processing of DR1-restricted determinants from the fusion protein of measles virus following two distinct pathways.
    Demotz S; Péléraux A
    Mol Immunol; 1996; 33(4-5):387-97. PubMed ID: 8676890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative abundance of two measles virus fusion protein peptide-DR1 complexes expressed by B cells is independent of the form of the antigen.
    Demotz S
    Cell Immunol; 1999 May; 193(2):202-8. PubMed ID: 10222063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation to HLA class II-restricted measles virus-specific T-cell clones can occur in the absence of the invariant chain.
    Sekaly RP; Jacobson S; Richert JR; Tonnelle C; McFarland HF; Long EO
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1209-12. PubMed ID: 3257576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.
    Jaraquemada D; Marti M; Long EO
    J Exp Med; 1990 Sep; 172(3):947-54. PubMed ID: 2388037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein.
    Muller CP; Ammerlaan W; Fleckenstein B; Krauss S; Kalbacher H; Schneider F; Jung G; Wiesmüller KH
    Int Immunol; 1996 Apr; 8(4):445-56. PubMed ID: 8671631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The processing routes determined by negatively charged residues in DR1-restricted T cell determinants.
    Robadey C; Ammerlaan W; Muller C; Cloutier I; Sékaly RP; Haefliger JA; Demotz S
    J Immunol; 1997 Oct; 159(7):3238-46. PubMed ID: 9317122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing of the DRB1*1103-restricted measles virus nucleoprotein determinant 185-199 in the endosomal compartment.
    Demotz S; Ammerlaan W; Fournier P; Muller CP; Barbey C
    Clin Exp Immunol; 1998 Nov; 114(2):228-35. PubMed ID: 9822281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient major histocompatibility complex class II-restricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells.
    Gerlier D; Trescol-Biémont MC; Varior-Krishnan G; Naniche D; Fugier-Vivier I; Rabourdin-Combe C
    J Exp Med; 1994 Jan; 179(1):353-8. PubMed ID: 8270880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
    Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI
    Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.
    Oxenius A; Bachmann MF; Ashton-Rickardt PG; Tonegawa S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3402-11. PubMed ID: 8566030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL.
    van Binnendijk RS; Poelen MC; Kuijpers KC; Osterhaus AD; Uytdehaag FG
    J Immunol; 1990 Mar; 144(6):2394-9. PubMed ID: 2107259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition.
    van Binnendijk RS; van Baalen CA; Poelen MC; de Vries P; Boes J; Cerundolo V; Osterhaus AD; UytdeHaag FG
    J Exp Med; 1992 Jul; 176(1):119-28. PubMed ID: 1613454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient MHC class II-restricted presentation of measles virus to T cells relies on its targeting to its cellular receptor human CD46 and involves an endosomal pathway.
    Gerlier D; Trescol-Biémont MC; Varior-Krishnan G; Naniche D; Fugier-Vivier I; Rabourdin-Combe C
    Cell Biol Int; 1994 May; 18(5):315-20. PubMed ID: 8049676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens.
    Jacobson S; Richert JR; Biddison WE; Satinsky A; Hartzman RJ; McFarland HF
    J Immunol; 1984 Aug; 133(2):754-7. PubMed ID: 6203977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective increased presentation of type II collagen by leupeptin.
    Manoury-Schwartz B; Chiocchia G; Lotteau V; Fournier C
    Int Immunol; 1997 Apr; 9(4):581-9. PubMed ID: 9138019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles-specific T cell clones derived from a twin with multiple sclerosis: genetic restriction studies.
    Richert JR; McFarland HF; McFarlin DE; Johnson AH; Woody JN; Hartzman RJ
    J Immunol; 1985 Mar; 134(3):1561-6. PubMed ID: 2578511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.